助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   前列腺增生症(bph) 的翻译结果: 查询用时:1.46秒
图标索引 在分类学科中查询
所有学科
更多类别查询

图标索引 历史查询
 

前列腺增生症bph     
相关语句
  “前列腺增生症(bph)”译为未确定词的双语例句
     Objective To investigate the effects of estrogen on the expression of Bcl-2,Bax and c-myc genes in the cells from transitional zone (TZ) of benign prostatic hyperplasia (BPH).
     目的 探讨大剂量外源性雌激素对良性前列腺增生症 (BPH )移行区 (TZ)细胞Bcl 2、Bax和c myc基因表达的影响 ,籍此了解雌激素对BPH的治疗机制。
短句来源
     Purpose: To study the expression and significance of PML in human prostate carcinoma and BPH tissue.
     目的 :探讨急性早幼粒细胞白血病基因 (PML)在人类前列腺癌 (PCa)组织、癌周围组织以及前列腺增生症 (BPH)前列腺组织中的表达及意义。
短句来源
     Methods: The expression of Survivin and VEGF in 22 normal prostate (NP), 47benign prostate hyperplasia(BPH) and 59 prostate carcinoma (Pca) was examined with immunohistochemistry.
     方法:采用免疫组化方法检测22例正常前列腺(NP)、47例良性前列腺增生症(BPH)和59例前列腺癌(Pca)组织中Survivin、VEGF蛋白的表达。
短句来源
     Objectives: The aim of our work is to explore the role and significanceof estrogen and its receptors in the development of benign prostatic hyperplasia(BPH) and prostatic cancer(PC) as well as their possible clinical application by investigating the expression of estrogen receptor subtypes , ER α、 ERβ in normal prostate (NP) 、 BPH and PC tissues, as well as in different grade of PC including WHO pathological, clinical and Gleason' s system.
     目的:通过测定雌激素受体(ER)亚型ER α、ER β在正常前列腺(NP)、前列腺增生症(BPH)、前列腺癌(PC)组织中及在PC不同WHO病理分级、临床分期、Gleason分级中的表达情况,探讨雌激素及其受体ER α、ER β与BPH及PC的关系。
短句来源
     Objective: To observe the clinical effect of Xiaolong mixture (消癃合剂) and Xiaolong powder (消癃散) in treating benign prostatic hyperplasia (BPH).
     目的:观察消癃合剂联合消癃散治疗良性前列腺增生症(BPH)的临床疗效。
短句来源
更多       
  相似匹配句对
     “Restoring Injection”Treating Benign Prostatic Hypertrophy (BPH)
     “回缩液”治疗前列腺增生(BPH)
短句来源
     Drug Therapy of Benign Prostatic Hyperplasia
     前列腺增生的药物治疗
短句来源
     Purpose:To analyse the reason of reoperation of benign prostatic hyperplasia (BPH).
     目的 :探讨前列腺增生 (BPH)再手术的原因。
短句来源
     Among them,475 patients were benign prostatic hyperplasia(BPH);
     其中良性前列腺增生(BPH)475例;
短句来源
     Elecyrochemotherapy for Benign Prostatic Hyperplasia
     前列腺增生的电化学治疗
短句来源
查询“前列腺增生症(bph)”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  prostatic hyperplasia (bph)
Benign prostatic hyperplasia (BPH) primarily affects middle-aged and elderly men.
      
Medical therapy for benign prostatic hyperplasia (BPH) attempts to duplicate the known benefits of prostatectomy without the associated morbidity.
      
Throughout the past decade, several minimally invasive therapies for benign prostatic hyperplasia (BPH) have emerged to challenge transurethral prostatectomy (TURP) in efficacy and safety.
      
Although histologic changes of benign prostatic hyperplasia (BPH) begin in men when they are in their thirties, symptomatic BPH characterized by lower urinary tract symptoms (LUTS) typically do not develop for several decades.
      
Medical treatment for the symptoms of benign prostatic hyperplasia (BPH) consists of α blockers and 5-α -reductase inhibitors.
      
更多          
  benign prostatic hyperplasia (bph)
Benign prostatic hyperplasia (BPH) primarily affects middle-aged and elderly men.
      
Medical therapy for benign prostatic hyperplasia (BPH) attempts to duplicate the known benefits of prostatectomy without the associated morbidity.
      
Throughout the past decade, several minimally invasive therapies for benign prostatic hyperplasia (BPH) have emerged to challenge transurethral prostatectomy (TURP) in efficacy and safety.
      
Although histologic changes of benign prostatic hyperplasia (BPH) begin in men when they are in their thirties, symptomatic BPH characterized by lower urinary tract symptoms (LUTS) typically do not develop for several decades.
      
Medical treatment for the symptoms of benign prostatic hyperplasia (BPH) consists of α blockers and 5-α -reductase inhibitors.
      
更多          
  prostate hyperplasia (bph)
We also recruited 40 subjects for control groups, 20 with benign prostate hyperplasia (BPH) and 20 healthy males with similar characteristics.
      
Benign prostate hyperplasia (BPH) is a disease of the aging male.
      
The usual treatments of benign prostate hyperplasia (BPH) including the alpha-blockers, the inhibitors of the 5-alpha reductase and the phytotherapy drugs allow significant improvements of the lower urinary tracts symptoms (LUTS).
      
Here, we analyzed the length of the CAG repeat of the AR gene in 1363 individuals, including patients with PC, benign prostate hyperplasia (BPH), and population controls.
      
Benign prostate hyperplasia (BPH) is a major disease and its non-surgical therapy a major area of interest.
      
更多          
  prostatic hypertrophy (bph)
A systematic study of testosterone metabolism in benign prostatic hypertrophy (BPH): In vitro results
      
The determination of steroid-receptors in human prostatic tissue from 68 patients with benign prostatic hypertrophy(BPH) and 36 patients with prostatic cancer by the method of cold agargel-electrophoresis is described.
      
2) The incorporation of labelled T into minced benign prostatic hypertrophy (BPH) tissue from subjects with high (40 ng/ml) hPr was measured and was found to be more than twice the uptake into tissue from those with low hPr (6.5±1.9 ng/ml).
      
Serum prostatic specific antigen (PA) and prostatic acid phosphatase (PAP) levels were measured in 113 untreated patients with prostatic cancer and in 137 patients with benign prostatic hypertrophy (BPH).
      
The binding of a novel radioligand, [3H]tamsulosin, to human prostatic membranes with benign prostatic hypertrophy (BPH) has been characterized.
      
更多          


Plasma testosterone (T), estradiol(E_2) and E_2/T ratio were determined in ten patients who had benign prostatic hypertrophy (BPH), and compared with those in ten cases who were senile male with non-prostatic hypertrophy (NPH). The results showed that (1)there was not proportion between index value of all sexual hormone and the age; (2) no correlation between levels of sexual hormone and the degree of prostatic hypertrophy was found; and (3)in plasma T value no si- gnificant difference between group BPH and...

Plasma testosterone (T), estradiol(E_2) and E_2/T ratio were determined in ten patients who had benign prostatic hypertrophy (BPH), and compared with those in ten cases who were senile male with non-prostatic hypertrophy (NPH). The results showed that (1)there was not proportion between index value of all sexual hormone and the age; (2) no correlation between levels of sexual hormone and the degree of prostatic hypertrophy was found; and (3)in plasma T value no si- gnificant difference between group BPH and group NPH was found (p>0.05). The E_2 and E_2/T ratio of group BPH were significantly higher than those of group NPH (P<0.01) .This data would suggest that BPH may be caused by hyq- er-estradiol and disbalance of proportion of estradiol to androgen hormone.

作者测定10例前列腺增生症(BPH)病人血浆睾酮(T),雌二醇(E_2)及E_2/T比值,并对照10例非前列腺增生症(NPH)男性老年者。结果显示:1、性激素各项指标值与年龄不成正比;2、性激素水平与前列腺增大程度不相关;3、BPH组与NPH组血浆T无显著差异(P>0.05),E_2及E_2/T前者比后者显著提高(P<0.01)。提示雌雄激素比例失衡可能是BPH的发病因素。

By the analysis of 15 cases of BPH treated with balloon dilatation and combining with literatures,the technical methods,indications,complications,mechanism and long-term efficacy of the balloon dilatation were discussed.Patients were performed for balloon dilatation to be of slight or middle enlargement of prostates and the hyperplasia in- volving the lateral lobes predominantly.The balloon dilatation was a safe,simple procedure and it may be a new alternative therapy for the patients who could not to undergo...

By the analysis of 15 cases of BPH treated with balloon dilatation and combining with literatures,the technical methods,indications,complications,mechanism and long-term efficacy of the balloon dilatation were discussed.Patients were performed for balloon dilatation to be of slight or middle enlargement of prostates and the hyperplasia in- volving the lateral lobes predominantly.The balloon dilatation was a safe,simple procedure and it may be a new alternative therapy for the patients who could not to undergo surgical prostectomy because of poor medical condition.The long-term efficacy of the procedure had yet to be determined.

笔者通过对15例球囊导管扩张术治疗良性前列腺增生症(BPH)的结果分析,结合有关文献资料,对球囊导管扩张术治疗 BPH 的技术方法、适应症、并发症、扩张机制及其远期疗效进行了讨论.球囊导管扩张术适宜于对两侧叶轻至中度 BPH 患者的治疗。该法安全、简便,为因身体状况等原因不宜接受外科手术治疗的 BPH 患者提供了一种新的治疗方法.球囊导管扩张术治疗 BPH 的远期疗效尚待研究.

The androgen receptors in biopsy specimens of 22 cases of human prostatic cancer(PC) were studied by radioligand binding assay. The cytoplasmic androgen receptor (AcR) and nuclear androgen receptor(AnR) densities wewe 305.70±461.68 and 363.04±391.44 pmol/g protein respectively, both were significantly higher than those of 36 benigh prostatic hypertrophy (BPH) and 9 normal prostate(NP). Among the prostatic cancers, the AnR/AcR ratios were significantly different between metastatic and primary cancers. This result...

The androgen receptors in biopsy specimens of 22 cases of human prostatic cancer(PC) were studied by radioligand binding assay. The cytoplasmic androgen receptor (AcR) and nuclear androgen receptor(AnR) densities wewe 305.70±461.68 and 363.04±391.44 pmol/g protein respectively, both were significantly higher than those of 36 benigh prostatic hypertrophy (BPH) and 9 normal prostate(NP). Among the prostatic cancers, the AnR/AcR ratios were significantly different between metastatic and primary cancers. This result suggested that there might be migration of AR from nucleus to cytosoi in the process of metastasis. The serum testosterone studied by RIA method are significantly lower than that of BPH and NP. Thawmounted autoradiography demonstrated that AR were mainly located in epithelial cells of the glandular tissue of prostate.

采用放射配基结合分析法测定人前列腺癌(PC)穿刺标本的雄激素受体(AR)含量,其胞浆受体(AcR)及胞核受体(AnR)分别为305.70±461.68,363.04±391.44pmol/g蛋白,与36例前列腺增生症(BPH)及9例正常前列腺组织含量相比均有显著性差异,显示前列腺癌的雄激素依赖性。22例前列腺癌患者中未转移组的AnR/AcR比值明显大于转移组,提示前列腺癌转移过程中AnR向胞浆转移的可能性。前列腺癌患者的血清睾酮水平明显低于前列腺增生症患者及正常人。放射自显影术显示雄激素受体定位以前列腺上皮细胞核为主,表明雄激素通过与核内受体结合调控肿瘤发生发展的可能性。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关前列腺增生症(bph)的内容
在知识搜索中查有关前列腺增生症(bph)的内容
在数字搜索中查有关前列腺增生症(bph)的内容
在概念知识元中查有关前列腺增生症(bph)的内容
在学术趋势中查有关前列腺增生症(bph)的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社